Streptococcal Infection Group B as Cause of Diseases Classified Elsewhere (Diagnosis) Clinical Trial
Official title:
The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel
| NCT number | NCT04222907 |
| Other study ID # | 0008-17 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | January 1, 2015 |
| Est. completion date | September 20, 2019 |
| Verified date | April 2017 |
| Source | Assuta Hospital Systems |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational [Patient Registry] |
Determination of GBS colonization rates in Pregnant Women insured with Maccabi Health Services, Doctors' Compliance Rates for Referral for Testing, test execution rates, and Early-onset GBS Disease (EOGBSD) Rates in Israel. Determine the relationship between conducting a GBS test in pregnant women and EOGBSD in Israel.
| Status | Completed |
| Enrollment | 54759 |
| Est. completion date | September 20, 2019 |
| Est. primary completion date | September 20, 2016 |
| Accepts healthy volunteers | |
| Gender | Female |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - All women with term pregnancies from 2015 to 2016 (until 20/9/16) insured by Maccabi Healthcare Services (MHS) Exclusion Criteria: - repeat pregnancies occurring in the same woman during the time period - multiple pregnancies - gestational age greater than 42 weeks due to probability of data inaccuracy - women with missing information |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Assuta Hospital Systems |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Attack rate of early-onset GBS disease (EOGBSD) | Attack rate of (EOGBSD) | 2015-2016 |